Gubra A/S
CPH: GUBRA.CO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Copenhagen
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Markus Rohrwild
- Employees
- 260
- Headquarters
- Horsholm, Denmark
- IPO year
- 2023
- Market cap
- DKK 5.3B
- Website
- https://www.gubra.dk
Loading GUBRA…
Loading profile data…Frequently asked questions about GUBRA
What does Gubra A/S (GUBRA.CO) do?
Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo...
Where does GUBRA.CO trade?
Gubra A/S (GUBRA.CO) trades on the NASDAQ Copenhagen.
What sector is GUBRA.CO in?
Gubra A/S (GUBRA.CO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Gubra A/S?
Markus Rohrwild is the chief executive officer of Gubra A/S (GUBRA.CO).
Where is Gubra A/S headquartered?
Gubra A/S is headquartered in Denmark.
Does GUBRA.CO pay a dividend?
Yes — Gubra A/S (GUBRA.CO) paid a trailing twelve-month dividend of DKK 61.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GUBRA.CO go public?
Gubra A/S (GUBRA.CO) completed its initial public offering in 2023.